Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beriplex P/N vs Plasma for Acute Major Bleeding Reversal
NCT00708435Phase 3Completed
- Sponsor
- CSL Limited
- Start
- Jun 2008
- Primary completion
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 6
01
Overview
A Phase 3 trial of balfaxar in hemorrhage, coagulopathy, sponsored by CSL Limited. Started Jun 2008; status: completed.
02
Drugs
balfaxar
03
Conditions
hemorrhagecoagulopathy
Beyond the preview
Go deeper on NCT00708435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00708435.